CD38-SADA pretargeted radioimmunotherapy (PRIT) with Lutetium 177 (Lu177)-DOTA in adult patients with relapsed or refractory non-Hodgkin lymphoma: A first-in-human phase 1 trial Meeting Abstract
| Authors: | Zain, J.; Wong, J.; Horwitz, S.; Pandit-Taskar, N.; Al-Janadi, A.; Mancini, B.; Khawaja, R.; Lee, C. Y.; Howansky, A.; Liles, D.; Burke, A.; Santich, B. H.; Fonnes, D. K.; Rajah, V.; LaFrance, N.; Russell, C. A. |
| Abstract Title: | CD38-SADA pretargeted radioimmunotherapy (PRIT) with Lutetium 177 (Lu177)-DOTA in adult patients with relapsed or refractory non-Hodgkin lymphoma: A first-in-human phase 1 trial |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 44341 |
| Language: | English |
| ACCESSION: | WOS:001410587900047 |
| DOI: | 10.1182/blood-2024-193628 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
-
668Horwitz -
345Pandit-Taskar
Related MSK Work